Mederi launches Stretta GERD treatment in the U.S.

April 12, 2010 by MassDevice staff

A decade after it first won 510(k) clearance from the Food & Drug Administration, Mederi Therapeutics Inc. launches its Stretta radiofrequency treatment for gastro-esophageal reflux disease.

Mederi logo

Ten years after it first won clearance from the Food & Drug Administration, Mederi Therapeutics Inc.'s Stretta treatment for gastro-esophageal reflux disease is hitting the market in the U.S.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp